Yahoo Web Search

  1. ACADIA Surges on Early Success of Nuplazid Dementia Study

    Zacks via Yahoo FinanceSep 10 15:41 PM

    ACADIA Pharmaceuticals Inc. ACAD announced that Nuplazid (pimavanserin) met the primary endpoint by showing statistically significant superiority over placebo in increasing the time to ...

  2. Renal Cell Carcinoma Space in Focus: Some Key Developments

    Zacks via Yahoo FinanceSep 13 13:36 PM

    In April 2019, the FDA had approved this combination for the same indication. Given its market potential, most pharma/biotech bigwigs are scurrying to grab a larger chunk of this pie. Evidently, the focus is on better and effective treatments.

  3. Roche RHHBY announced positive data on the immuno-oncology drug, Tecentriq (atezolizumab), from a late-stage study in patients with advanced non-small cell lung cancer (NSCLC). The phase III ...

  4. Horizon (HZNP) Up 36.7% YTD: Pipeline Development in Focus

    Zacks via Yahoo FinanceSep 12 14:02 PM

    Shares of Horizon Therapeutics plc HZNP have surged 36.7% year to date against the industry’s decline of 1.9%. The company has been focusing on expanding its orphan drug business. This is evident ...

  5. Buy 5 Top Dow Stocks to Gain From Index's Rally

    Zacks via Yahoo FinanceSep 10 11:11 AM

    In line with the broader market, the Dow 30 Index ---- popularly known as the blue-chip index of Wall Street ---- gained in previous four successive trading sessions, posting its longest winning ...

  6. An experimental Amgen Inc drug that targets a specific genetic mutation reduced tumor size in around half of advanced lung cancer patients given the highest dose in a small, early-stage ...

  7. Roche (RHHBY) Reports Positive Data on Tecentriq & MS Drug

    Zacks via Yahoo FinanceSep 12 13:09 PM

    Roche RHHBY announced positive data on the immuno-oncology drug, Tecentriq (atezolizumab), from a late-stage study in patients with advanced non-small cell lung cancer (NSCLC). The phase III ...

  8. Breast Cancer Drugs May Inflame Lungs Per FDA Safety Alert

    Zacks via Yahoo FinanceSep 16 12:33 PM

    The FDA approves new warnings about inflammation risk to be added to labels of Pfizer's (PFE) Ibrance, Eli Lilly's (LLY) Verzenio and Novartis' (NVS) Kisqali.

  9. Retina Society Annual Meeting 2019 Annual Meeting – Sept. in London Global Summit On Cardiology & Heart Diseases – Sept. in Dubai European Association for the Study of Diabetes, or EASD, 55th annual meeting – Sept.

  10. Edited Transcript of IMV.TO earnings conference call or presentation 9-Aug-19 12:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceSep 02 15:40 PM

    Looking ahead, I'm pleased to confirm that we have now enrolled 16 additional patients of the expanded monotherapy arm, and that time, we expect to provide a top line clinical results from this ...

  1. Ads
    related to MERCK & CO., INC